Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002317.SZ

Guangdong Zhongsheng Pharmaceutical Co., Ltd. Free Cash Flow Yield on January 14, 2025: -1.83%

Guangdong Zhongsheng Pharmaceutical Co., Ltd. Free Cash Flow Yield is -1.83% on January 14, 2025, a -48.94% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

Guangdong Zhongsheng Pharmaceutical Co., Ltd. 52-week high Free Cash Flow Yield is -1.03% on March 19, 2024, which is 43.78% above the current Free Cash Flow Yield.
Guangdong Zhongsheng Pharmaceutical Co., Ltd. 52-week low Free Cash Flow Yield is -1.88% on January 13, 2025, which is -2.51% below the current Free Cash Flow Yield.
Guangdong Zhongsheng Pharmaceutical Co., Ltd. average Free Cash Flow Yield for the last 52 weeks is -1.47%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

Shenzhen Stock Exchange: 002317.SZ

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

CEO	Mr. Yong Hong Chen
IPO Date	Dec. 11, 2009
Location	China
Headquarters	Information Industry Park
Employees	1,732
Sector	Health Care
Industries Pharmaceuticals

Description

Guangdong Zhongsheng Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. The company offers Chinese and chemical medicines. It is also involved in the research and development of products in the fields of ophthalmology, cardiovascular, cerebrovascular, respiratory, digestive, diabetes, tumor, and senile degenerative diseases. The company was founded in 1979 and is based in Dongguan, China.

Key trends

Past 5 years